Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Translational Medicine
Published in: Journal of Translational Medicine 1/2013

Open Access 01-12-2013 | Review

Stem cells: a new paradigm for disease modeling and developing therapies for age-related macular degeneration

Authors: Heather Melville, Matthew Carpiniello, Kia Hollis, Andrew Staffaroni, Nady Golestaneh

Published in: Journal of Translational Medicine | Issue 1/2013

Login to get access

Abstract

Age-related macular degeneration (AMD) is the leading cause of blindness in people over age 55 in the U.S. and the developed world. This condition leads to the progressive impairment of central visual acuity. There are significant limitations in the understanding of disease progression in AMD as well as a lack of effective methods of treatment. Lately, there has been considerable enthusiasm for application of stem cell biology for both disease modeling and therapeutic application. Human embryonic stem cells and induced pluripotent stem cells (iPSCs) have been used in cell culture assays and in vivo animal models. Recently a clinical trial was approved by FDA to investigate the safety and efficacy of the human embryonic stem cell-derived retinal pigment epithelium (RPE) transplantation in sub-retinal space of patients with dry AMD These studies suggest that stem cell research may provide both insight regarding disease development and progression, as well as direction for therapeutic innovation for the millions of patients afflicted with AMD.
Literature
1.
Gehrs KM, Anderson DH, Johnson LV, Hageman GS: Age related macular degeneration: emerging pathogenetic and therapeutic concepts. Ann Med. 2006, 38: 450-471. 10.1080/07853890600946724.PubMed
2.
Rein DB, Wittenborn JS, Zhang X: Forecasting age-related macular degeneration through the year 2005. The potential impact of new treatments. Arch Ophthalmol. 2009, 127: 533-540. 10.1001/archophthalmol.2009.58.PubMed
3.
Nowak J: Age related macular degeneration: pathogenesis and therapy. Pharmacol Rep. 2006, 58: 353-363.PubMed
4.
Abdelsalam A, Del Priore L, Zarbin MA: Drusen in Age-related macular degeneration: pathogenesis, natural course, and laser photocoagulation–induced regression. Surv Ophthalmol. 1999, 44: 1-29. 10.1016/S0039-6257(99)00072-7.PubMed
5.
Ferris FL, Fine SL, Hyman L: Age-related macular degeneration and blindness due to neovascular maculopathy. Arch Ophthalmol. 1984, 102: 1640-1642. 10.1001/archopht.1984.01040031330019.PubMed
6.
Bull ND, Martin KR: Concise review: toward stem cell-based therapies for retinal neurodegenerative diseases. Stem Cells. 2011, 29: 1170-1175. 10.1002/stem.676.PubMed
7.
8.
Couch SM, Bakri SJ: Review of combination therapies for neovascular Age-related macular degeneration. Semin Ophthalmol. 2011, 26: 114-120. 10.3109/08820538.2011.577130.PubMed
9.
Marchetti V, Krohne TU, Friedlander DF, Friedlander M: Stemming vision loss with stem cells. J Clin Invest. 2010, 120: 3012-3021. 10.1172/JCI42951.PubMedCentralPubMed
10.
Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM: Embryonic stem cell lines derived from human blastocysts. Science. 1998, 282: 1145-1147.PubMed
11.
Takahashi K, Yamanaka S: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006, 126: 663-676. 10.1016/j.cell.2006.07.024.PubMed
12.
Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S: Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007, 131: 861-872. 10.1016/j.cell.2007.11.019.PubMed
13.
Buchholz DE, Hikita ST, Rowland TJ, Friedrich AM, Hinman CR, Johnson LV, Clegg DO: Derivation of functional retinal pigmented epithelium from induced pluripotent stem cells. Stem Cells. 2009, 27: 2427-2434. 10.1002/stem.189.PubMed
14.
Carr A, Vugler AA, Hikita ST, Lawrence JM, Gias C, Chen LL, Buchholz DE, Ahmado A, Semo M, Smart MJK, Hasan S, da Cruz L, Johnson LV, Clegg DO, Coffey PJ: Protective effects of human iPS-derived retinal pigment epithelium cell transplantation in the retinal dystrophic Rat. PLoS One. 2009, 4: e8152-10.1371/journal.pone.0008152.PubMedCentralPubMed
15.
Hirami Y, Osakada F, Takahashi K, Okita K, Yamanaka S, Ikeda H, Yoshimura N, Takahashi M: Generation of retinal cells from mouse and human induced pluripotent stem cells. Neurosci Lett. 2009, 458: 126-131. 10.1016/j.neulet.2009.04.035.PubMed
16.
Lu B, Malcuit C, Wang S, Girman S, Francis P, Lemieux L, Lanza R, Lund R: Long-term safety and function of RPE from human embryonic stem cells in preclinical models of macular degeneration. Stem Cells. 2009, 27: 2126-2135. 10.1002/stem.149.PubMed
17.
Liao J, Yu J, Huang K, Hu J, Diemer T, Ma Z, Dvash T, Yang X, Travis GH, Williams DS, Bok D, Fan G: Molecular signature of primary retinal pigment epithelium and stem-cell-derived RPE cells. Hum Mol Genet. 2010, 19: 4229-4238. 10.1093/hmg/ddq341.PubMedCentralPubMed
18.
Kokkinaki M, Sahibzada N, Golestaneh N: Human induced pluripotent stem-derived retinal pigment epithelium (RPE) cells exhibit Ion transport, membrane potential, polarized vascular endothelial growth factor secretion, and gene expression pattern similar to native RPE. Stem Cells. 2011, 29: 825-835. 10.1002/stem.635.PubMedCentralPubMed
19.
Du H, Lim SL, Grob S, Zhang K: Induced pluripotent stem cell therapies for geographic atrophy of age-related macular degeneration. Semin Ophthalmol. 2011, 26: 216-224. 10.3109/08820538.2011.577498.PubMedCentralPubMed
20.
Bok D: The retinal pigmented epithelium: a versatile partner in vision. J Cell Sci. 1993, 17: 189-195.
21.
Boulton M, Dayhaw-Barker P: The role of the retinal pigment epithelium: topographical variation and ageing changes. Eye. 2001, 15: 384-389. 10.1038/eye.2001.141.PubMed
22.
Strauss O: The retinal pigment epithelium in visual function. Physiol Rev. 2005, 85: 845-881. 10.1152/physrev.00021.2004.PubMed
23.
Wimmers S, Karl MO, Strauss O: Ion channels in the RPE. Prog Retin Eye Res. 2007, 26: 263-301. 10.1016/j.preteyeres.2006.12.002.PubMed
24.
Cai J, Nelson KC, Wu M, Sternberg P, Jones DP: Oxidative damage and protection of the RPE. Prog Retin Eye Res. 2000, 19: 205-221. 10.1016/S1350-9462(99)00009-9.PubMed
25.
Negi AMM: EXperimental serous retinal detachment and focal pigment epithelial damage. Arch Ophthalmol. 1984, 102: 445-449. 10.1001/archopht.1984.01040030359038.PubMed
26.
Feeney-Burns L, Gao CL, Tidwell M: Lysosomal enzyme cytochemistry of human RPE, Bruch’s membrane and drusen. Invest Ophthalmol Vis Sci. 1987, 28: 1138-1147.PubMed
27.
Farkas T, Sylvester V, Archer D, Altona M: The histochemistry of drusen. Am J Ophthalmol. 1971, 71: 1206-1215.PubMed
28.
Farkas T, Sylvester V, Archer D: The ultrastructure of drusen. Am J Ophthalmol. 1971, 71: 1196-1205.PubMed
29.
Yoshida T, Ohno-Matsui K, Ichinose S, Sato T, Iwata N, Saido TC, Hisatomi T, Mochizuki M, Morita I: The potential role of amyloid beta in the pathogenesis of age-related macular degeneration. J Clin Invest. 2005, 115: 2793-2800. 10.1172/JCI24635.PubMedCentralPubMed
30.
Buschini E, Piras A, Nuzzi R, Vercelli A: Age related macular degeneration and drusen: neuroinflammation in the retina. Prog Neurobiol. 2011, 95: 14-25. 10.1016/j.pneurobio.2011.05.011.PubMed
31.
Ohno-Matsui K: Parallel findings in age-related macular degeneration and Alzheimer’s disease. Prog Retin Eye Res. 2011, 30: 217-238. 10.1016/j.preteyeres.2011.02.004.PubMed
32.
Hageman GS, Mullins RF, Russell SR, Johnson LV, Anderson DH: Vitronectin is a constituent of ocular drusen and the vitronectin gene is expressed in human retinal pigmented epithelial cells. FASEB J. 1999, 13: 477-484.PubMed
33.
Leu ST, Batni S, Radeke MJ, Johnson LV, Anderson DH, Clegg DO: Drusen are cold spots for proteolysis: expression of matrix metalloproteinases and their tissue inhibitor proteins in Age-related macular degeneration. Exp Eye Res. 2002, 74: 141-154. 10.1006/exer.2001.1112.PubMed
34.
Wang L, Clark ME, Crossman DK, Kojima K, Messinger JD, Mobley JA, Curcio CA: Abundant lipid and protein components of drusen. PLoS One. 2010, 5: 10329-10.1371/journal.pone.0010329.
35.
Johnson LV, Ozaki S, Staples MK, Erickson PA, Anderson DH: A potential role for immune complex pathogenesis in drusen formation. Exp Eye Res. 2000, 70: 441-449. 10.1006/exer.1999.0798.PubMed
36.
Ishibashi T, Patterson R, Ohnishi Y, Inomata H, Ryan S: Formation of drusen in the human eye. Am J Ophthalmol. 1986, 101: 342-353.PubMed
37.
Anderson DH, Mullins RF, Hageman GS, Johnson LV: A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol. 2002, 134: 411-431. 10.1016/S0002-9394(02)01624-0.PubMed
38.
39.
Leveziel N, Tilleul J, Puche N, Zerbib J, Laloum F, Querques G, Souied EH: Genetic factors associated with Age-related macular degeneration. Ophthalmologica. 2011, 226: 87-102. 10.1159/000328981.PubMed
40.
Chen W, Stambolian D, Edwards AO, Branham KE, Othman M, Jakobsdottir J, Tosakulwong N, Pericak-Vance MA, Campochiaro PA, Klein ML, Tan PL, Conley YP, Kanda A, Kopplin L, Li Y, Augustaitis KJ, Karoukis AJ, Scott WK, Agarwal A, Kovach JL, Schwartz SG, Postel EA, Brooks M, Baratz KH, Brown WL, Brucker AJ, Orlin A, Brown G, Ho A, Regillo C, Donoso L, Tian L, Complications of Age-Related Macular Degeneration Prevention Trial (CAPT) Research Group: Genetic variants near TIMP3 and high-density lipoprotein–associated loci influence susceptibility to age-related macular degeneration. Proc Natl Acad Sci. 2010, 107: 7401-7406. 10.1073/pnas.0912702107.PubMedCentralPubMed
41.
Haines JL, Hauser MA, Schmidt S, Scott WK, Olson LM, Gallins P, Spencer KL, Kwan SY, Noureddine M, Gilbert JR, Schnetz-Boutaud N, Agarwal A, Postel EA, Pericak-Vance MA: Complement factor H variant increases the risk of Age-related macular degeneration. Science. 2005, 308: 419-421. 10.1126/science.1110359.PubMed
42.
Gold B, Merriam JE, Zernant J, Hancox LS, Taiber AJ, Gehrs K, Cramer K, Neel J, Bergeron J, Barile GR, Smith RT, Hageman GS, Dean M, Allikmets R: Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat Genet. 2006, 38: 458-462. 10.1038/ng1750.PubMedCentralPubMed
43.
Hughes AE, Orr N, Esfandiary H, Diaz-Torres M, Goodship T, Chakravarthy U: A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration. Nat Genet. 2006, 38: 1173-1177. 10.1038/ng1890.PubMed
44.
Maller JB, Fagerness JA, Reynolds RC, Neale BM, Daly MJ, Seddon JM: Variation in complement factor 3 is associated with risk of age-related macular degeneration. Nat Genet. 2007, 39: 1200-1201. 10.1038/ng2131.PubMed
45.
Spencer KL, Hauser MA, Olson LM, Schmidt S, Scott WK, Gallins P, Agarwal A, Postel EA, Pericak-Vance MA, Haines JL: Protective effect of complement factor B and complement component 2 variants in age-related macular degeneration. Hum Mol Genet. 2007, 16: 1986-1992. 10.1093/hmg/ddm146.PubMed
46.
Yates JRW, Sepp T, Matharu BK, Khan JC, Thurlby DA, Shahid H, Clayton DG, Hayward C, Morgan J, Wright AF, Armbrecht AM, Dhillon B, Deary IJ, Redmond E, Bird AC, Moore AT: Complement C3 variant and the risk of Age-related macular degeneration. N Engl J Med. 2007, 357: 553-561. 10.1056/NEJMoa072618.PubMed
47.
Jakobsdottir J, Conley YP, Weeks DE, Ferrell RE, Gorin MB: C2 And CFB genes in Age-related maculopathy and joint action with CFH and LOC387715 genes. PLoS One. 2008, 3: e2199-10.1371/journal.pone.0002199.PubMedCentralPubMed
48.
Spencer KL, Hauser MA, Olson LM, Schmidt S, Scott WK, Gallins P, Agarwal A, Postel EA, Pericak-Vance MA, Haines JL: Deletion of CFHR3 and CFHR1 genes in age-related macular degeneration. Hum Mol Genet. 2008, 17: 971-977.PubMed
49.
Edwards AO, Ritter R, Abel KJ, Manning A, Panhuysen C, Farrer LA: Complement factor H polymorphism and Age-related macular degeneration. Science. 2005, 308: 421-424. 10.1126/science.1110189.PubMed
50.
DeWan A, Liu M, Hartman S, Zhang SS, Liu DTL, Zhao C, Tam POS, Chan WM, Lam DSC, Snyder M, Barnstable C, Pang CP, Hoh J: HTRA1 Promoter polymorphism in Wet Age-related macular degeneration. Science. 2006, 314: 989-992. 10.1126/science.1133807.PubMed
51.
Yang Z, Camp NJ, Sun H, Tong Z, Gibbs D, Cameron DJ, Chen H, Zhao Y, Pearson E, Li X, Chien J, DeWan A, Harmon J, Bernstein PS, Shridhar V, Zabriskie NA, Hoh J, Howes K, Zhang K: A variant of the HTRA1 gene increases susceptibility to Age-related macular degeneration. Science. 2006, 314: 992-993. 10.1126/science.1133811.PubMed
52.
Zhang X, Bok D: Transplantation of retinal pigment epithelial cells and immune response in the subretinal space. Invest Ophthalmol Vis Sci. 1998, 39: 1021-1027.PubMed
53.
Baird PN, Guida E, Chu DT, Vu HTV, Guymer RH: The ε2 and ε4 alleles of the apolipoprotein gene Are associated with Age-related macular degeneration. Invest Ophthalmol Vis Sci. 2004, 45: 1311-1315. 10.1167/iovs.03-1121.PubMed
54.
Schmidt S, Haines J, Postel E, Agarwal A, Kwan S, Gilbert J, Pericak-Vance M, Scott W: Joint effects of smoking history and APOE genotypes in age-related macular degeneration. Mol Vis. 2006, 11: 941-949.
55.
Haines JL, Schnetz-Boutaud N, Schmidt S, Scott WK, Agarwal A, Postel EA, Olson L, Kenealy SJ, Hauser M, Gilbert JR, Pericak-Vance MA: Functional candidate genes in Age-related macular degeneration: significant association with VEGF, VLDLR, and LRP6. Invest Ophthalmol Vis Sci. 2006, 47: 329-335. 10.1167/iovs.05-0116.PubMed
56.
SanGiovanni JP, Arking DE, Iyengar SK, Elashoff M, Clemons TE, Reed GF, Henning AK, Sivakumaran TA, Xu X, DeWan A, Agrón E, Rochtchina E, Sue CM, Wang JJ, Mitchell P, Hoh J, Francis PJ, Klein ML, Chew EY, Chakravarti A: Mitochondrial DNA variants of respiratory complex I that uniquely characterize haplogroup T2 Are associated with increased risk of Age-related macular degeneration. PLoS One. 2009, 4: e5508-10.1371/journal.pone.0005508.PubMedCentralPubMed
57.
Jones M, Manwaring N, Wang JJ, Rochtchina E, Mitchell P, Sue CM: MItochondrial dna haplogroups and age-related maculopathy. Arch Ophthalmol. 2007, 125: 1235-1240. 10.1001/archopht.125.9.1235.PubMed
58.
Udar N, Atilano SR, Memarzadeh M, Boyer DS, Chwa M, Lu S, Maguen B, Langberg J, Coskun P, Wallace DC, Nesburn AB, Khatibi N, Hertzog D, Le K, Hwang D, Kenney MC: Mitochondrial DNA haplogroups associated with Age-related macular degeneration. Invest Ophthalmol Vis Sci. 2009, 50: 2966-2974. 10.1167/iovs.08-2646.PubMed
59.
Cideciyan AV, Aleman TS, Swider M, Schwartz SB, Steinberg JD, Brucker AJ, Maguire AM, Bennett J, Stone EM, Jacobson SG: Mutations in ABCA4 result in accumulation of lipofuscin before slowing of the retinoid cycle: a reappraisal of the human disease sequence. Hum Mol Genet. 2004, 13: 525-534. 10.1093/hmg/ddh048.PubMed
60.
Fraga MF: Genetic and epigenetic regulation of aging. Curr Opin Immunol. 2009, 21: 446-453. 10.1016/j.coi.2009.04.003.PubMed
61.
Swaroop A, Chew EY, Bowes Rickman C, Abecasis GR: Unraveling a multifactorial late-onset disease: from genetic susceptibility to disease mechanisms for Age-related macular degeneration. Annu Rev Genom Human Genet. 2009, 10: 19-43. 10.1146/annurev.genom.9.081307.164350.
62.
Cvekl A, Mitton KP: Epigenetic regulatory mechanisms in vertebrate eye development and disease. Heredity. 2010, 105: 135-151. 10.1038/hdy.2010.16.PubMedCentralPubMed
63.
Seddon JM, Reynolds R, Shah HR, Rosner B: Smoking, dietary betaine, methionine, and vitamin D in monozygotic twins with discordant macular degeneration: epigenetic implications [abstract]. Ophthalmology. 2011, 118: 1386-1394.PubMedCentralPubMed
64.
Wei L, Liu B, Tuo J, Shen D, Chen P, Li Z, Liu X, Ni J, Dagur P, Sen H, Jawad S, Ling D, Park S, Chakrabarty S, Meyerle C, Agron E, Ferris F, Chew E, McCoy J, Blum E, Francis P, Klein M, Guymer R, Baird P, Chan C, Nussenblatt R: Hypomethylation of the IL17RC promoter associates with Age-related macular degeneration [abstract]. Cell Reports. 2012, 2: 1151-1158. 10.1016/j.celrep.2012.10.013.PubMedCentralPubMed
65.
Hunter A, Spechler PA, Cwanger A, Song Y, Zhang Z, Ying G, Hunter AK, deZoeten E, Dunaief JL: DNA methylation is associated with altered gene expression in AMD. Invest Ophthalmol Vis Sci. 2012, 53: 2089-2105. 10.1167/iovs.11-8449.PubMedCentralPubMed
66.
Suuronen T, Nuutinen T, Ryhänen T, Kaarniranta K, Salminen A: Epigenetic regulation of clusterin/apolipoprotein J expression in retinal pigment epithelial cells. Biochem Biophys Res Commun. 2007, 357: 397-401. 10.1016/j.bbrc.2007.03.135.PubMed
67.
Hjelmeland LM: Dark matters in AMD genetics: epigenetics and stochasticity. Invest Ophthalmol Vis Sci. 2011, 52: 1622-1631. 10.1167/iovs.10-6765.PubMedCentralPubMed
68.
Neale BM, Fagerness J, Reynolds R, Sobrin L, Parker M, Raychaudhuri S, Tan PL, Oh EC, Merriam JE, Souied E, Bernstein PS, Li B, Frederick JM, Zhang K, Brantley MA, Lee AY, Zack DJ, Campochiaro B, Campochiaro P, Ripke S, Smith RT, Barile GR, Katsanis N, Allikmets R, Daly MJ, Seddon JM: Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC). PNAS. 2010, 107: 7395-7400. 10.1073/pnas.0912019107.PubMedCentralPubMed
69.
Lim LS, Mitchell P, Seddon JM, Holz FG, Wong TY: Age-related macular degeneration. Lancet. 2012, 379: 1728-1738. 10.1016/S0140-6736(12)60282-7.PubMed
70.
Idelson M, Alper R, Obolensky A, Ben-Shushan E, Hemo I, Yachimovich-Cohen N, Khaner H, Smith Y, Wiser O, Gropp M, Cohen MA, Even-Ram S, Berman-Zaken Y, Matzrafi L, Rechavi G, Banin E, Reubinoff B: Directed differentiation of human embryonic stem cells into functional retinal pigment epithelium cells. Cell Stem Cell. 2009, 5: 396-408. 10.1016/j.stem.2009.07.002.PubMed
71.
Salero E, Blenkinsop T, Corneo B, Harris A, Rabin D, Stern J, Temple S: Adult human RPE Can Be activated into a multipotent stem cell that produces mesenchymal derivatives [abstract]. Cell Stem Cell. 2012, 10: 88-95. 10.1016/j.stem.2011.11.018.PubMed
72.
73.
Bessho K, Rodanant N, Bartsch DG, Cheng L, Koh H, Freeman WR: Effect of subthreshold infrared laser treatment for drusen regression on macular autofluorescence in patients with Age-related macular degeneration. Retina. 2005, 25: 981-9. 10.1097/00006982-200512000-00005.PubMed
74.
75.
Kaiser RS, Berger JW, Maguire MG, Ho AC, Javornik NB, Choroidal Neovascularization Prevention Trial Study Group: Laser burn intensity and the risk for choroidal neovascularization in the CNVPT fellow Eye study. Arch Ophthalmol. 2001, 119: 826-832. 10.1001/archopht.119.6.826.PubMed
76.
Ferrara N: Vascular endothelial growth factor and age-related macular degeneration: from basic science to therapy. Nat Med. 2010, 16: 1107-1111. 10.1038/nm1010-1107.PubMed
77.
Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE, Nguyen HV, Aiello LM, Ferrara N, King GL: Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994, 331: 1480-1487. 10.1056/NEJM199412013312203.PubMed
78.
Veritti D, Sarao V, Lanzetta P: Neovascular Age-related macular degeneration. Ophthalmologica. 2012, 227: 11-20. 10.1159/000337154.PubMed
79.
Ferrara N, Damico L, Shams N, Lowman H, Kim R: Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular Age-related macular degeneration. Retina. 2006, 26: 859-10.1097/01.iae.0000242842.14624.e7.PubMed
80.
Nakao S, Arima M, Ishikawa K, Kohno R, Kawahara S, Miyazaki M, Yoshida S, Enaida H, Hafezi-Moghadam A, Kono T, Ishibashi T: Intravitreal anti-VEGF therapy blocks inflammatory cell infiltration and Re-entry into the circulation in retinal angiogenesis. Invest Ophthalmol Vis Sci. 2012, 53: 4323-4328. 10.1167/iovs.11-9119.PubMed
81.
Martin D, Maguire MG, Ying G, Grunwald J, Fine S, Jaffe G: Ranibizumab and Bevacizumab for neovascular Age-related macular degeneration. N Engl J Med. 2011, 364: 1897-1908.PubMed
82.
Martin DF, Maguire MG, Fine SL, Ying G, Jaffe GJ, Grunwald JE, Toth C, Redford M, Ferris FL: Ranibizumab and Bevacizumab for treatment of neovascular Age-related macular degeneration: Two-year results. Ophthalmology. 2012, 119: 1388-1398. 10.1016/j.ophtha.2012.03.053.PubMedCentralPubMed
83.
Levine JP, Marcus I, Sorensen JA, Spaide RF, Cooney MJ, Freund B: Macular hemorrhage in neovascular age-related macular degeneration after stabilization with antiangiogenic therapy. Retina. 2009, 29: 1074-1079. 10.1097/IAE.0b013e3181b09443.PubMed
84.
Ohji M, Fujikado T, Kusaka S, Hayashi A, Hosohata J, Ikuno Y, Sawa M, Kubota A, Hashida N, Tano Y: Comparison of three techniques of foveal translocation in patients with subfoveal choroidal neovascularization resulting from age-related macular degeneration. Am J Ophthalmol. 2001, 132: 888-896. 10.1016/S0002-9394(01)01255-7.PubMed
85.
Lüke M, Ziemssen F, Völker M, Altpeter E, Beutel J, Besch D, Bartz-Schmidt K, Gelisken F: Full macular translocation (FMT) versus photodynamic therapy (PDT) with verteporfin in the treatment of neovascular age-related macular degeneration: 2-year results of a prospective, controlled, randomised pilot trial (FMT-PDT). Graefes Arch Clin Exp Ophthalmol. 2009, 247: 745-754. 10.1007/s00417-009-1050-5.PubMed
86.
van Meurs JC, Van Den Biesen PR: Autologous retinal pigment epithelium and choroid translocation in patients with exudative age-related macular degeneration: short-term follow-up. Am J Ophthalmol. 2003, 136: 688-695. 10.1016/S0002-9394(03)00384-2.PubMed
87.
MacLaren RE, Pearson RA, MacNeil A, Douglas RH, Salt TE, Akimoto M, Swaroop A, Sowden JC, Ali RR: Retinal repair by transplantation of photoreceptor precursors. Nature. 2006, 444: 203-207. 10.1038/nature05161.PubMed
88.
MacLaren RE, Uppal GS, Balaggan KS, Tufail A, Munro PMG, Milliken AB, Ali RR, Rubin GS, Aylward GW, da Cruz L: Autologous transplantation of the retinal pigment epithelium and choroid in the treatment of neovascular Age-related macular degeneration. Ophthalmology. 2007, 114: 561-570.e2. 10.1016/j.ophtha.2006.06.049.PubMed
89.
Gouras P, Flood M, Kjeldbye H: Transplantation of cultured human retinal cells to monkey retina. An Acad Bras Cienc. 1984, 56: 431-434.PubMed
90.
Binder S, Stanzel BV, Krebs I, Glittenberg C: Transplantation of the RPE in AMD. Prog Retin Eye Res. 2007, 26: 516-554. 10.1016/j.preteyeres.2007.02.002.PubMed
91.
da Cruz L, Chen FK, Ahmado A, Greenwood J, Coffey P: RPE transplantation and its role in retinal disease. Prog Retin Eye Res. 2007, 26: 598-635. 10.1016/j.preteyeres.2007.07.001.PubMed
92.
Limb GA, Daniels JT: Ocular regeneration by stem cells: present status and future prospects. Br Med Bull. 2008, 85: 47-61. 10.1093/bmb/ldn008.PubMed
93.
Ohta K, Ito A, Tanaka H: Neuronal stem/progenitor cells in the vertebrate eye. Dev Growth Differ. 2008, 50: 253-259. 10.1111/j.1440-169X.2008.01006.x.PubMed
94.
Osakada F, Ikeda H, Mandai M, Wataya T, Watanabe K, Yoshimura N, Akaike A, Sasai Y, Takahashi M: Toward the generation of rod and cone photoreceptors from mouse, monkey and human embryonic stem cells. Nat Biotech. 2008, 26: 215-224. 10.1038/nbt1384.
95.
Binder S, Krebs I, Hilgers R, Abri A, Stolba U, Assadoulina A, Kellner L, Stanzel BV, Jahn C, Feichtinger H: Outcome of transplantation of autologous retinal pigment epithelium in Age-related macular degeneration: a prospective trial. Invest Ophthalmol Vis Sci. 2004, 45: 4151-4160. 10.1167/iovs.04-0118.PubMed
96.
Binder S: Scaffolds for retinal pigment epithelium (RPE) replacement therapy. Br J Ophthalmol. 2011, 95: 441-442. 10.1136/bjo.2009.171926.PubMed
97.
Treharne AJ, Grossel MC, Lotery AJ, Thomson HA: The chemistry of retinal transplantation: the influence of polymer scaffold properties on retinal cell adhesion and control. Br J Ophthalmol. 2011, 95: 768-773. 10.1136/bjo.2010.184002.PubMed
98.
Del Priore LV, Tezel TH, Kaplan HJ: Maculoplasty for age-related macular degeneration: reengineering Bruch’s membrane and the human macula. Prog Retin Eye Res. 2006, 25: 539-562. 10.1016/j.preteyeres.2006.08.001.PubMed
99.
Crafoord S, Algvere PV, Seregard S, Kopp ED: Long-term outcome of RPE allografts to the subretinal space of rabbits. Acta Ophthalmol. 1999, 77: 247-254. 10.1034/j.1600-0420.1999.770301.x.
100.
Tamiya S, Liu L, Kaplan HJ: Epithelial-mesenchymal transition and proliferation of retinal pigment epithelial cells initiated upon loss of cell-cell contact. Invest Ophthalmol Vis Sci. 2010, 51: 2755-2763. 10.1167/iovs.09-4725.PubMed
101.
MacLaren RE, Pearson RA: Stem cell therapy and the retina. Eye. 2007, 21: 1352-1359. 10.1038/sj.eye.6702842.PubMed
102.
Djojosubroto M, Bollotte F, Wirapati P, Radtke F, Stamenkovic I, Arsenijevic Y: Chromosomal number aberrations and transformation in adult mouse retinal stem cells In vitro. Invest Ophthalmol Vis Sci. 2009, 50: 5975-5987. 10.1167/iovs.08-3091.PubMed
103.
MacNeil A, Pearson RA, MacLaren RE, Smith AJ, Sowden JC, Ali RR: Comparative analysis of progenitor cells isolated from the iris, pars plana, and ciliary body of the adult porcine Eye. Stem Cells. 2007, 25: 2430-2438. 10.1634/stemcells.2007-0035.PubMed
104.
West EL, Pearson RA, MacLaren RE, Sowden JC, Ali RR: Cell transplantation strategies for retinal repair. Prog Brain Res. 2009, 175: 3-21.PubMedCentralPubMed
105.
Tucker BA, Redenti SM, Jiang C, Swift JS, Klassen HJ, Smith ME, Wnek GE, Young MJ: The use of progenitor cell/biodegradable MMP2–PLGA polymer constructs to enhance cellular integration and retinal repopulation. Biomaterials. 2010, 31: 9-19. 10.1016/j.biomaterials.2009.09.015.PubMed
106.
Streilein JW, Ma N, Wenkel H, Fong Ng T, Zamiri P: Immunobiology and privilege of neuronal retina and pigment epithelium transplants. Vision Res. 2002, 42: 487-495. 10.1016/S0042-6989(01)00185-7.PubMed
107.
Sheridan C, Williams R, Grierson I: Basement membranes and artificial substrates in cell transplantation. Graefes Arch Clin Exp Ophthalmol. 2004, 242: 68-75. 10.1007/s00417-003-0800-z.PubMed
108.
Tezel TH, Del Priore LV, Kaplan HJ: Reengineering of aged Bruch’s membrane to enhance retinal pigment epithelium repopulation. Invest Ophthalmol Vis Sci. 2004, 45: 3337-3348. 10.1167/iovs.04-0193.PubMed
109.
Gullapalli VK, Sugino IK, Van Patten Y, Shah S, Zarbin MA: Impaired RPE survival on aged submacular human Bruch’s membrane. Exp Eye Res. 2005, 80: 235-248. 10.1016/j.exer.2004.09.006.PubMed
110.
Tomita M, Lavik E, Klassen H, Zahir T, Langer R, Young MJ: Biodegradable polymer composite grafts promote the survival and differentiation of retinal progenitor cells. Stem Cells. 2005, 23: 1579-1588. 10.1634/stemcells.2005-0111.PubMed
111.
Atala A: Tissue engineering for bladder substitution. World J Urol. 2000, 18: 364-370. 10.1007/s003450000152.PubMed
112.
Shin K, Jayasuriya AC, Kohn DH: Effect of ionic activity products on the structure and composition of mineral self assembled on three-dimensional poly(lactide-co-glycolide) scaffolds. J Biomed Mater Res A. 2007, 83: 1076-1086.PubMedCentralPubMed
113.
Tao S, Young C, Redenti S, Zhang Y, Klassen H, Desai T, Young MJ: Survival, migration and differentiation of retinal progenitor cells transplanted on micro-machined poly(methyl methacrylate) scaffolds to the subretinal space. Lab Chip. 2007, 7: 695-701. 10.1039/b618583e.PubMed
114.
Neeley WL, Redenti S, Klassen H, Tao S, Desai T, Young MJ, Langer R: A microfabricated scaffold for retinal progenitor cell grafting. Biomaterials. 2008, 29: 418-426. 10.1016/j.biomaterials.2007.10.007.PubMedCentralPubMed
115.
Redenti S, Neeley WL, Rompani S, Saigal S, Yang J, Klassen H, Langer R, Young MJ: Engineering retinal progenitor cell and scrollable poly(glycerol-sebacate) composites for expansion and subretinal transplantation. Biomaterials. 2009, 30: 3405-3414. 10.1016/j.biomaterials.2009.02.046.PubMedCentralPubMed
116.
Ghosh F, Neeley WL, Arner K, Langer R: Selective removal of photoreceptor cells in vivo using the biodegradable elastomer poly(glycerol sebacate). Tissue Eng Part A. 2011, 17: 1675-1682. 10.1089/ten.tea.2008.0450.PubMedCentralPubMed
117.
Redenti S, Tao S, Yang J, Gu P, Klassen H, Saigal S, Desai T, Young MJ: Retinal tissue engineering using mouse retinal progenitor cells and a novel biodegradable, thin-film poly(e-caprolactone) nanowire scaffold. J Ocul Biol Dis Infor. 2008, 1: 19-29. 10.1007/s12177-008-9005-3.PubMedCentralPubMed
118.
Lund R, Wang S, Klimanskaya I, Holmes T, Ramos-Kelsey R, Lu B, Girman S, Bischoff N, Sauvé Y, Lanza R: Human embryonic stem cell-derived cells rescue visual function in dystrophic RCS rats. Cloning Stem Cells. 2006, 8: 189-199. 10.1089/clo.2006.8.189.PubMed
119.
Meyer JS, Katz ML, Maruniak JA, Kirk MD: Embryonic stem cell-derived neural progenitors incorporate into degenerating retina and enhance survival of host photoreceptors. Stem Cells. 2006, 24: 274-283. 10.1634/stemcells.2005-0059.PubMedCentralPubMed
120.
Vugler A, Carr AJ, Lawrence J, Chen LL, Burrell K, Wright A, Lundh P, Semo M, Ahmado A, Gias C, da Cruz L, Moore H, Andrews P, Walsh J, Coffey P: Elucidating the phenomenon of HESC-derived RPE: anatomy of cell genesis, expansion and retinal transplantation. Exp Neurol. 2008, 214: 347-361. 10.1016/j.expneurol.2008.09.007.PubMed
121.
Osakada F, Ikeda H, Sasai Y, Takahashi M: Stepwise differentiation of pluripotent stem cells into retinal cells. Nat Protocols. 2009, 4: 811-824.PubMed
122.
Klimanskaya I, Hipp J, Rezai K, West M, Atala A, Lanza R: Derivation and comparative assessment of retinal pigment epithelium from human embryonic stem cells using transcriptomics. Stem Cells and Cloning. 2004, 6: 217-245.
123.
Davis AA, Bernstein PS, Bok D, Turner J, Nachtigal M, Hunt RC: A human retinal pigment epithelial cell line that retains epithelial characteristics after prolonged culture. Invest Ophthalmol Vis Sci. 1995, 36: 955-964.PubMed
124.
Maherali N, Sridharan R, Xie W, Utikal J, Eminli S, Arnold K, Stadtfeld M, Yachechko R, Tchieu J, Jaenisch R, Plath K, Hochedlinger K: Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell. 2007, 1: 55-70. 10.1016/j.stem.2007.05.014.PubMed
125.
Chin MH, Mason MJ, Xie W, Volinia S, Singer M, Peterson C, Ambartsumyan G, Aimiuwu O, Richter L, Zhang J, Khvorostov I, Ott V, Grunstein M, Lavon N, Benvenisty N, Croce CM, Clark AT, Baxter T, Pyle AD, Teitell MA, Pelegrini M, Plath K, Lowry WE: Induced pluripotent stem cells and embryonic stem cells Are distinguished by gene expression signatures [abstract]. Cell Stem Cell. 2009, 5: 111-123. 10.1016/j.stem.2009.06.008.PubMedCentralPubMed
126.
Doi A, Park I, Wen B, Murakami P, Aryee MJ, Irizarry R, Herb B, Ladd-Acosta C, Rho J, Loewer S, Miller J, Schlaeger T, Daley GQ, Feinberg AP: Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat Genet. 2009, 41: 1350-1353. 10.1038/ng.471.PubMedCentralPubMed
127.
Kim K, Doi A, Wen B, Ng K, Zhao R, Cahan P, Kim J, Aryee MJ, Ji H, Ehrlich LIR, Yabuuchi A, Takeuchi A, Cunniff KC, Hongguang H, Mckinney-Freeman S, Naveiras O, Yoon TJ, Irizarry RA, Jung N, Seita J, Hanna J, Murakami P, Jaenisch R, Weissleder R, Orkin SH, Weissman IL, Feinberg AP, Daley GQ: Epigenetic memory in induced pluripotent stem cells. Nature. 2010, 467: 285-290. 10.1038/nature09342.PubMedCentralPubMed
128.
Polo JM, Liu S, Figueroa ME, Kulalert W, Eminli S, Tan KY, Apostolou E, Stadtfeld M, Li Y, Shioda T, Natesan S, Wagers AJ, Melnick A, Evans T, Hochedlinger K: Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat Biotech. 2010, 28: 848-855. 10.1038/nbt.1667.
129.
Lister R, Pelizzola M, Kida YS, Hawkins RD, Nery JR, Hon G, Antosiewicz-Bourget J, O'Malley R, Castanon R, Klugman S, Downes M, Yu R, Stewart R, Ren B, Thomson JA, Evans RM, Ecker JR: Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature. 2011, 471: 68-73. 10.1038/nature09798.PubMedCentralPubMed
130.
Ohi Y, Qin H, Hong C, Blouin L, Polo JM, Guo T, Qi Z, Downey SL, Manos PD, Rossi DJ, Yu J, Hebrok M, Hochedlinger K, Costello JF, Song JS, Ramalho-Santos M: Incomplete DNA methylation underlies a transcriptional memory of somatic cells in human iPS cells. Nat Cell Biol. 2011, 13: 541-549. 10.1038/ncb2239.PubMedCentralPubMed
131.
Cherry AC, Daley G: Reprogramming cellular identity for regenerative medicine. Cell. 2012, 148: 1110-1122. 10.1016/j.cell.2012.02.031.PubMedCentralPubMed
132.
Robinton DA, Daley GQ: The promise of induced pluripotent stem cells in research and therapy. Nature. 2012, 481: 295-305. 10.1038/nature10761.PubMedCentralPubMed
133.
Hu Q, Friedrich AM, Johnson LV, Clegg DO: Memory in induced pluripotent stem cells: reprogrammed human retinal-pigmented epithelial cells show tendency for spontaneous redifferentiation. Stem Cells. 2010, 28: 1981-1991. 10.1002/stem.531.PubMed
134.
Schwartz SD, Hubschman J, Heilwell G, Franco-Cardenas V, Pan CK, Ostrick RM, Mickunas E, Gay R, Klimanskaya I, Lanza R: Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet. 2012, 379: 713-720. 10.1016/S0140-6736(12)60028-2.PubMed
135.
Lamba DA, McUsic A, Hirata RK, Wang P, Russell D, Reh TA: Generation, purification and transplantation of photoreceptors derived from human induced pluripotent stem cells. PLoS One. 2010, 10.1371/journal.pone.0008763.e8763.,
Metadata
Title
Stem cells: a new paradigm for disease modeling and developing therapies for age-related macular degeneration
Authors
Heather Melville
Matthew Carpiniello
Kia Hollis
Andrew Staffaroni
Nady Golestaneh
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2013
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/1479-5876-11-53

Other articles of this Issue 1/2013

Journal of Translational Medicine 1/2013 Go to the issue

Research

Dynamics of bone healing after osteotomy with piezosurgery or conventional drilling– histomorphometrical, immunohistochemical, and molecular analysis

Research

Comparison of the diagnostic values of circulating steroid hormones, VEGF-A, PIGF, and ADAM12 in women with ectopic pregnancy

Research

Shedding LIGHT (TNFSF14) on the tumor microenvironment of colorectal cancer liver metastases

Research

Flotillin-2 is associated with breast cancer progression and poor survival outcomes

Research

A proteomic view of isoproterenol induced cardiac hypertrophy: Prohibitin identified as a potential biomarker in rats

Research

Betaine supplement enhances skeletal muscle differentiation in murine myoblasts via IGF-1 signaling activation
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits